Topical application of buspirone for treatment of pathological conditions associated with immune responses
AssigneeBeth Israel Deaconess Medical Center, Inc.
InventorsRichard J. Sharpe, Kenneth A. Arndt, Stephen J. Galli
Life of this patent
Estimating the term…
Abstract
A method for the treatment of a cutaneous, ocular, or mucosal pathological condition which is associated with an immune response in a human or other mammal, that includes topical application of an effective amount of buspirone or a buspirone derivative or its pharmaceutically acceptable salt, optionally in a pharmaceutically-acceptable diluent or carrier for topical application.
Claims12
A method for the treatment of a cutaneous, ocular, or mucosal pathology associated with an immune response in a human or other mammal that includes topical application of an effective amount of buspirone or its pharmaceutically acceptable salt, other than a quaternary salt, optionally in a pharmaceutically acceptable diluent or carrier for topical application.
Dependencies are inferred from the claim text.